Michael Silverman

Pharmaceutical and biotechnology clinical development strategy and management, especially for development-stage companies. Projects include IND planning and preparation; FDA interactions; Phase 1, Phase 2, first-in-man, and proof-of principle clinical trials; small molecules, biotechnology products, and vaccines/immunotherapeutics. Clinical research and development consulting to senior-level management (CEO, COO, CSO).